Global Digital Insomnia Therapeutics Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034

February 20, 2025 01:15 PM GMT | By EIN Presswire
 Global Digital Insomnia Therapeutics Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, February 20, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

The expansive global market for digital insomnia therapeutics is poised to display impressive growth trends over the next few years. From $3.27 billion in 2024, the market is projected to reach $3.49 billion in 2025, representing a compound annual growth rate CAGR of 6.64%. The increase is largely due to an increased focus on sleep disorder education, advancements in cross-platform compatibility, an emphasis on eco-friendly and sustainable digital therapeutic options, as well as a rising focus on mental health. This thriving market is projected to further expand to $4.47 billion in 2029 at a CAGR of 6.38%, fueled by technological advancements in digital health, AI and machine learning, and increased investment in sleep research.

What is Driving the Growth of the Digital Insomnia Therapeutics Market?

The digital insomnia therapeutics market growth is largely driven by the increasing adoption of digital health solutions. These digital platforms and technologies play a pivotal role in enhancing healthcare delivery, improving patient outcomes, and empowering individuals to manage their health effectively. This rising adoption is due to the increasing demand for accessible and cost-effective healthcare solutions, the growing prevalence of chronic diseases, heightened awareness of preventive care, and the expansion of telehealth services. Digital insomnia therapeutics, through their technology-driven solutions such as mobile apps and wearable devices, help monitor, diagnose, and manage sleep disorders. This results in better overall health outcomes and integration with broader healthcare systems. For instance, according to Rock Health, a US-based corporation, in 2022, 80% of respondents reported having used telemedicine at some point in their lives, a significant increase from 72% in 2021.

Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20750&type=smp

Which Companies are Pioneering the Digital Insomnia Therapeutics Market?

Leading companies in the digital insomnia therapeutics market are Pear Therapeutics Inc., Zuellig Pharma Holdings Limited, Calm.com Inc., Headspace Inc., Big Health Inc., Click Therapeutics Inc., Silvercloud Health Limited, Nox Health Group Inc., OPTT Inc., Curve Health Inc., Bodymatter Inc., Sana Health Group, SleepCogni Limited, Stellar Sleep, Somnus Therapeutics Inc., SleepScore Labs, HoneyNaps USA Inc., Sliiip, Neurovalens Ltd., and WELT Corp.

What are the Latest Trends in Digital Insomnia Therapeutics?

In an attempt to stay ahead of the curve, major players in the digital insomnia therapeutics market are striving to develop advanced solutions like software-based mobile apps designed to offer personalized, accessible, and cost-effective treatment options for managing insomnia. In addition to sleep tracking features, these apps integrate elements such as relaxation exercises, cognitive behavioral therapy, and personalized sleep recommendations. Big Health Inc., a US-based mental health services company, for example, received United States Food and Drug Administration approval for SleepioRx in August 2024.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/digital-insomnia-therapeutics-global-market-report

How is the Digital Insomnia Therapeutics Market Segmented Globally?

The digital insomnia therapeutics market has been segmented along various dimensions. By type, it includes sleep tracking apps, relaxation and meditation apps, Cognitive-Behavioral Therapy For Insomnia CBT-I, wearable devices, and other types. Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and other distribution channels. By application, the segments are medical and household. Furthermore, sub-segments under each category provide a detailed classification like sleep tracking apps being further subdivided into basic sleep monitoring apps, advanced sleep monitoring apps, and smart alarm apps.

What is the Regional Outlook for the Digital Insomnia Therapeutics Market?

In 2024, North America was the largest region in the digital insomnia therapeutics market, with other key regions including Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa, also significant contributors to market revenue.


Browse Through More Similar Reports By The Business Research Company:
Leukemia Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report
Bipolar Disorder Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report
Peptide Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Offering detailed research and insights through 15000+ reports spanning 27 industries in 60+ geographies, The Business Research Company has built a reputation for delivering comprehensive, data-rich studies. With 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders, we empower you with the information you need to stay ahead in the game.

Get in touch:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us: [email protected]

Stay connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next